Thelansis

Community-Acquired Pneumonia (CAP) Market Outlook Thelansis’s “Community-Acquired Pneumonia (CAP) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Community-Acquired Pneumonia (CAP) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest ...

Community-Acquired Pneumonia (CAP) Market Outlook Thelansis’s “Community-Acquired Pneumonia (CAP) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Community-Acquired Pneumonia (CAP) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Community-Acquired Pneumonia (CAP) Overview Community-acquired pneumonia (CAP) denotes an acute infection affecting the pulmonary parenchyma in individuals devoid of recent hospitalization within 14 days and not residing in nursing homes or long-term care facilities. The etiology of CAP encompasses two broad categories: Typical agents (e.g., Streptococcus pneumoniae, Haemophilus influenzae, Moraxella c...

 Community-Acquired Pneumonia (CAP) is an acute pulmonary parenchymal infection in an individual who has not been hospitalized in the last 14-days and is not a resident of a nursing home or long-term care facility. The pathogen causing Community-acquired pneumonia is classified into; Typical agents (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, Group A Streptococci, anaerobes, and gram-negative organisms), and Atypical agents (Legionella, Mycoplasma, Chlamydia pneumoniae, and C. psittaci) globally. H. influenzae and S. pneumoniae are the two most common causes of bacterial pneumonia. Colonization of the pharynx with pathogens, followed by micro-aspiration, is the mechanism of entry into the lower respiratory tract. Other mechanisms include hematogenous spread and macro-aspiration. In the interaction between the pathogen and host pulmonary defence, pneumonia develops if the host defence is weak or overcome by high inoculum or virulen...